News
The 2024 Porsche Cayenne is a highly desirable midsize luxury SUV with a special driver appeal, enhanced this year by a range of upgrades....
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
News
TILT Holdings Inc. (OTCQB:TLLTF) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants Lynn Ricci – Head of IR and...
News
This article was written by Follow Power Hedge has been covering both traditional and renewable energy since 2010. He targets primarily international companies of...
News
Proximus (OTCPK:BGAOF) has been an exceptionally poor performer these last years. But we see some hope for Proximus as markets are unlikely to be...
News
Mortgage rates have risen to their highest levels in more than 20 years, making it harder to afford a home. And yet, out of...
News
Introduction The economics of REITs as an asset class is influenced by two cycles. There is the space market cycle which has to do...
News
Investment Thesis Evertec (NYSE:EVTC) is pursuing an ambitious M&A growth strategy, recently purchasing payments and fintech companies in Brazil, in order to diversify their...
News
Introduction The economic crisis that is going on in Argentina right now is quite frankly scary to look at. The company is experiencing hyperinflation...
News
In the past decade, the American urban landscape has transformed remarkably, with certain cities emerging as meteoric growth hubs. The pace of their expansion...
News
The home construction sector is notorious for its “boom and bust” cycle. During rising home prices, high demand, and low existing home inventories, residential...
News
Corporate issuance further pressures longer-term Treasury yields, amid expectations of bad inflation “surprises.” Share buybacks getting a lot more expensive, but no problem either....
News
Introduction Founded in 1989, Michigan-based Vericel (NASDAQ:VCEL) is a commercial-stage biopharmaceutical leader specializing in advanced therapies for sports medicine and severe burn care. It...
